| Description | SNP gene mutations in cancer cell lines identified by microarray |
| Measurement | single nucleotide polymorphism by microarray |
| Association | gene-cell line associations by mutation of gene in cell line |
| Category | genomics |
| Resource | Klijn et al., Nat. Biotechnol., 2015 |
| Citation(s) | |
| Last Updated | 2015 Apr 06 |
| Stats |
|
| API | |
| Script | |
| Downloads |
Attribute Similarity
Gene Attribute
Gene Similarity
676 sets of genes mutated in cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
| Gene Set | Description |
|---|---|
| 105KC | cell line derived from cartilage |
| 143B | Human fibroblast osteosarcoma cell line lacking the thymidine kinase (TK) gene. |
| 23132/87 | |
| 501A | cell line derived from skin |
| 537 MEL | cell line derived from skin |
| 59M | |
| 624 MEL | Human melanoma cell line. |
| 769-P | |
| 786-O | Human renal cell adenocarcinoma cell line, established from a 58 years old caucasian male. |
| 888 | Human melanoma cell line. |
| 928 MEL | cell line derived from skin |
| A-375 | |
| A-427 | |
| A-431 | Human epidermoid carcinoma established from the solid tumor of an 85-year-old woman; cells were reported to have large numbers of EGF binding sites; cell line was used as indicator cell line for anti-TGF binding. |
| A-498 | |
| A-673 | |
| A172 | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.). |
| A2058 | Human skin melanoma cell line, established from a 43 years adult caucasian male. |
| A2780 | Human ovarian carcinoma cell line. |
| A3/KAW | |
| A4/FUK | |
| A549 | Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin. |
| ABC-1 | |
| ACHN | |
| AGS | |
| AMO-1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| AN3 CA | |
| ASPC-1 | |
| ATRFLOX | disease: colorectal carcinoma |
| BEN | Human lung carcinoma; established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung. |
| BFTC-905 | |
| BFTC-909 | disease: carcinoma, transitional cell |
| BHY | Oral squamous cell carcinoma cell line. |
| BICR 10 | cell line derived from oral cavity |
| BICR 22 | cell line derived from upper aerodigestive tract |
| BICR 31 | cell line derived from upper_aerodigestive_tract |
| BICR 78 | cell line derived from oral cavity |
| BJAB | The malignant human B-cell-line BJAB is a EBV-negative Burkitt-like lymphoma cell line. |
| BT-20 | Human, Caucasian, breast, carcinoma cell line. Morphology: epithelial-like; species: human, Caucasian female 74 years old; tissue: breast; tumor: carcinoma. |
| BT-474 | |
| BT-483 | |
| BT-549 | |
| BXPC-3 | Human pancreatic adenocarcinoma cell line, established from a 61 year old human female. |
| C-33 A | |
| C170 | cell line derived from colon |
| C2BBE1 | The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution. |
| C32 | |
| C32TG | |
| C3A | |
| CA SKI | A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.). |
| CA46 | |
| CACO-2 | A immortal human colon-derived cell line cell that has the characteristics: Human colon carcinoma. Backup of ECA86010202. |
| CAKI-1 | |
| CAKI-2 | |
| CAL 27 | Human tongue squamous cell carcinoma established from the poorly differentiated squamous cell carcinoma of the tongue removed from a 56-year-old man before treatment in 1982. |
| CAL 54 | |
| CAL-120 | disease: adenocarcinoma, breast |
| CAL-12T | |
| CAL-148 | disease: adenocarcinoma, breast |
| CAL-85-1 | disease: adenocarcinoma, breast |
| CAL51 | |
| CALU-1 | |
| CALU-3 | |
| CALU-6 | |
| CAMA-1 | |
| CAOV-3 | |
| CAPAN-1 | |
| CAPAN-2 | |
| CAR-1 | Human rectal carcinoma cell line. |
| CCRF-SB | |
| CFPAC-1 | This line was derived from a pancreatic duct adenocarcinoma (liver metastasis) from a patient with cystic fibrosis. |
| CHAGO-K-1 | |
| CHL-1 | |
| CHP-212 | |
| CI-1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| CL-11 | Human lung adenocarcinoma cell line. |
| CL-34 | cell line derived from large_intestine |
| CL-40 | cell line derived from large_intestine |
| COCM-1 | cell line derived from colon |
| COLO 201 | A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. This B cell lines derived from Mongoloid Minority Groups in South America. |
| COLO 205 | |
| COLO 206F | |
| COLO 320DM | disease: colorectal adenocarcinoma |
| COLO 678 | |
| COLO 679 | |
| COLO 680N | disease: carcinoma, squamous cell |
| COLO 699 | Non-small cell lung cancer cell line. |
| COLO 741 | disease: carcinoma, colon |
| COLO 792 | disease: malignant melanoma |
| COLO 794 | cell line derived from skin |
| COLO 800 | |
| COLO 829 | disease: malignant melanoma |
| COLO 849 | |
| COLO 853 | |
| COLO 857 | |
| COLO-704 | |
| COLO-783 | |
| COLO-818 | |
| COR-L26 | cell line derived from lung |
| COR-L279 | disease: carcinoma, small cell |
| COR-L47 | disease: carcinoma, lung small cell |
| COR-L88 | disease: carcinoma, lung small cell |
| COV318 | cell line derived from ovary |
| COV362 | cell line derived from ovary |
| COV413A | cell line derived from ovary |
| COV413B | cell line derived from ovary |
| COV434 | cell line derived from ovary |
| COV504 | cell line derived from ovary |
| COV644 | cell line derived from ovary |
| CPC-N | disease: carcinoma, small cell |
| CW-2 | A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable. |
| CX-1 | Human colon adenocarcinoma cell line; established from the tumor tissue of a 44-year-old woman with well-differentiated colon adenocarcinoma in 1984; cell line is a subclone of cell line HT-29. |
| DAN-G | |
| DAUDI | A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011. |
| DB | disease: large cell lymphoma |
| DEOC-1 | A immortal human cell line cell that has the characteristics: Human cell line derived from malignant melanoma. Cell growth is slow. |
| DETROIT 562 | |
| DLD-1 | Human colon adenocarcinoma established from a colorectal adenocarcinoma. |
| DMS 273 | disease: carcinoma, small cell |
| DMS 454 | disease: carcinoma, small cell |
| DMS 53 | |
| DMS 79 | |
| DOHH-2 | |
| DOK | |
| DOR 13 | cell line derived from ovary |
| DU 145 | A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.). |
| DU4475 | disease: ductal carcinoma |
| DV-90 | |
| EB-3 | disease: Burkitts lymphoma |
| EB1 | |
| EB2 | disease: Burkitts lymphoma (B lymphocyte primary) |
| EBC-1 | A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line. TKG0481(Deposited from Tohoku Univ.). |
| EFM-19 | |
| EFM-192A | |
| EFM-192B | |
| EFM-192C | |
| EFO-27 | Human ovary adenocarcinoma cell line; established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979. |
| EJM | cell line derived from haematopoietic_and_lymphoid_tissue |
| EKVX | Non-small cell lung adenocarcinoma cell line. |
| EPLC-272H | disease: carcinoma, epidermoid |
| ES-2 | |
| EVSA-T | |
| FADU | Cell line derived from squamous cell carcinoma of the hypopharynx. |
| FARAGE | disease: non-Hodgkins lymphoma |
| FU97 | |
| G-361 | Homo sapiens (human); skin; malignant melanoma cell line; established from a 31 year old caucasian male. |
| G-402 | A human cell line derived from some renal leiomyeloblastoma |
| G111 | cell line derived from brain |
| G112 | cell line derived from brain |
| G118 | cell line derived from brain |
| G120 | cell line derived from brain |
| G121 | cell line derived from brain |
| G122 | cell line derived from brain |
| G124 | cell line derived from brain |
| G130 | cell line derived from brain |
| G140 | cell line derived from brain |
| G141 | cell line derived from brain |
| G142 | cell line derived from brain |
| G22 | cell line derived from brain |
| G28T | cell line derived from brain |
| G44 | cell line derived from brain |
| G59 | cell line derived from brain |
| G61 | cell line derived from brain |
| G84 | cell line derived from brain |
| G96 | cell line derived from brain |
| GA-10 | disease: Burkitts lymphoma |
| GP2D | |
| GP5D | |
| GR-M | |
| GRANTA-519 | disease: lymphoma, B cell |
| GTL-16 | cell line derived from stomach |
| H322T | cell line derived from lung |
| HBL-100 | |
| HCA-7 | HCA-7 cell line was originally derived from human colonic carcinoma. |
| HCC-15 | |
| HCC1011 | cell line derived from kidney |
| HCC1143 | disease: primary ductal carcinoma |
| HCC1162 | cell line derived from uterus |
| HCC1171 | |
| HCC1187 | disease: primary ductal carcinoma |
| HCC12 | cell line derived from kidney |
| HCC1263 | cell line derived from colon |
| HCC1319 | cell line derived from kidney |
| HCC1359 | |
| HCC1395 | |
| HCC1419 | disease: primary ductal carcinoma |
| HCC1428 | disease: adenocarcinoma (mammary gland primary) |
| HCC1482 | cell line derived from uterus |
| HCC1493 | cell line derived from breast |
| HCC1500 | disease: primary ductal carcinoma |
| HCC1534 | cell line derived from lung |
| HCC1569 | disease: primary metaplastic carcinoma |
| HCC1576 | cell line derived from adrenal |
| HCC1599 | disease: primary ductal carcinoma |
| HCC1806 | disease: primary acantholytic squamous cell carcinoma |
| HCC193 | |
| HCC1937 | |
| HCC1954 | |
| HCC202 | disease: primary ductal carcinoma |
| HCC2157 | disease: primary ductal carcinoma |
| HCC2218 | disease: primary ductal carcinoma |
| HCC2270 | cell line derived from lung |
| HCC2279 | cell line derived from lung |
| HCC2302 | cell line derived from lung |
| HCC2688 | cell line derived from breast |
| HCC2885 | cell line derived from lung |
| HCC2911 | cell line derived from breast |
| HCC2935 | |
| HCC33 | cell line derived from lung |
| HCC364 | cell line derived from lung |
| HCC366 | |
| HCC38 | |
| HCC4006 | |
| HCC4011 | cell line derived from lung |
| HCC4017 | cell line derived from lung |
| HCC44 | |
| HCC461 | |
| HCC515 | |
| HCC60 | cell line derived from ovary |
| HCC630 | cell line derived from ovary |
| HCC70 | disease: primary ductal carcinoma |
| HCC78 | |
| HCC827 | |
| HCC89 | cell line derived from kidney |
| HCT 116 | Human colon colorectal carcinoma cell line from a male organism. Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man. |
| HCT-15 | |
| HCT-8 | |
| HEC-1-A | |
| HEL | Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis. |
| HELA | Human cervix carcinoma established from the epitheloid cervix carcinoma of a 31-year-old black woman in 1951. Later diagnosis changed to adenocarcinoma, first aneuploid, continuously cultured human cell line. |
| HEP G2 | Human hepatocellular carcinoma, established from the tumor tissue of a 15-year-old argentine boy with hepatocellular carcinoma in 1975. |
| HEP-2 | A immortal human uterine cervix-derived cell line cell that has the characteristics: Supports growth of arvovirus and measles virus. A sabuline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.). |
| HEY | Human ovarian carcinoma cell line. |
| HGC-27 | This human gastric carcinoma cell line was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histological as undifferentiated carcinoma. |
| HL-60 | Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976. |
| HM7 | High-mucin variant cell line, derived from parental cell line LS174T. |
| HMY-1 | cell line derived from skin |
| HN | Oral squamous cell carcinoma cell line. |
| HNT-34 | A immortal human blood cell line cell that has the characteristics: AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. |
| HOP-62 | Non-small cell lung adenocarcinoma cell line. |
| HOP-92 | Non-small cell lung adenocarcinoma cell line. |
| HPAC | |
| HPAF-II | |
| HS 255.T | |
| HS 294T | Human melanoma cell line. |
| HS 38.T | |
| HS 578T | |
| HS 675.T | disease: colorectal cancer |
| HS 683 | Human brain glioma cell line. Hs 683 was isolated from explant cultures of a glioma taken from the left temporal lobe of a 76 year old male Caucasian. |
| HS 695T | disease: amelanotic melanoma (skin primary) |
| HS 69ST | cell line derived from skin |
| HS 746T | disease: gastric carcinoma (stomach primary |
| HS 766T | Human pancreatic cancer cell line. |
| HS 839.T | |
| HS 852.T | |
| HS 895.T | disease: melanoma (skin primary) |
| HS 936.T | |
| HS 940.T | disease: malignant melanoma |
| HS-SULTAN | |
| HT | disease: diffuse mixed lymphoma; B lymphoblast |
| HT-1080 | |
| HT-115 | Human colon carcinoma cell line. |
| HT-144 | Homo sapiens (human), morphology: fibroblast, tissue: metastatic site: subcutaneous tissue malignant melanoma, established from a 29-year-old caucasian men. |
| HT-29 | |
| HT-55 | |
| HUH-1 | cell line derived from liver |
| HUH-7 | HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. |
| HUP-T3 | |
| HUP-T4 | |
| IGR-37 | |
| IGROV-1 | |
| IM-95 | cell line derived from stomach |
| IM-95M | cell line derived from stomach |
| IMR-32 | Human neuroblastoma, established from an abdominal mass (diagnosed as neuroblastoma) of a 1-year-old caucasian boy in 1967. |
| IPC-298 | |
| JEKO-1 | |
| JHH-1 | cell line derived from liver |
| JHH-2 | cell line derived from liver |
| JHH-4 | cell line derived from liver |
| JHH-5 | cell line derived from liver |
| JHH-7 | cell line derived from liver |
| JIMT-1 | |
| JIYOYE | disease: Burkitts lymphoma |
| JJ012 | Human chondrosarcoma cell line. |
| JJN-3 | cell line derived from haematopoietic_and_lymphoid_tissue |
| JL-1 | cell line derived from pleura |
| JURKAT, CLONE E6-1 | disease: acute T cell leukemia |
| K-562 | Human chronic myeloid leukemia in blast crisis established from the pleural effusion of a 53-year-old woman with chronic myeloid leukemia (CML) in blast crisis in 1970. |
| KARPAS-1106P | cell line derived from lymph node |
| KARPAS-422 | Human B cell lymphoma cell line; established from the pleural effusion of a 73-year-old woman with B cell non-Hodgkin lymphoma (intraabdominal, diffuse large cell lymphoma, refractory, terminal) in 1987. |
| KARPAS-620 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KASUMI-1 | Human acute myelocytic leukemia cell line; derived from the peripheral blood of a 7-year-old japanese boy with acute myelocytic leukemia in relapse after bone marrow transplantation. |
| KATO III | |
| KCI-MOH1 | cell line derived from pancreas |
| KELLY | |
| KG-1 | A immortal human bone marrow-derived cell line cell that has the characteristics: Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+ |
| KHM-1B | cell line derived from haematopoietic_and_lymphoid_tissue |
| KLE | |
| KLM-1 | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. RCB1972 is derived from the same patient. TKG0490 (Deposited from Tohoku Univ.). |
| KM-12 | Human colon carcinoma cell line. |
| KMM-1 | A immortal mouse cell line cell that has the characteristics: Human myeloma. Lambda- chain producing. |
| KMS-11 | KMS-11 cell line was derived from four patients with multiple myeloma. These cells represent a later stage of B-cell differentiation, and shows characteristics of plasma cells by secreting surface kappa chain immunoglobulins. |
| KMS-12-BM | cell line derived from haematopoietic_and_lymphoid_tissue |
| KMS-12-PE | cell line derived from bone marrow |
| KMS-21BM | cell line derived from haematopoietic_and_lymphoid_tissue |
| KMS-26 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KMS-27 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KMS-28BM | cell line derived from haematopoietic_and_lymphoid_tissue |
| KMS-28PE | cell line derived from blood |
| KMS-34 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KNS-62 | |
| KP-2 | Human pancreatic cancer cell line of primary pancreatic origin. |
| KP-3 | Human pancreatic cancer cell line, obtained from liver metastases of pancreatic tumors. |
| KP4 | A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3. |
| KPL-1 | |
| KPL-4 | cell line derived from breast |
| KU812 | A immortal human blood cell line cell that has the characteristics: Chronic myelogeneous leukemia, Ph1 chromosome (+),basophi-like cells. |
| KURAMOCHI | |
| KYSE-140 | disease: carcinoma, squamous cell |
| KYSE-150 | Human esophageal squamous cell carcinoma cell line; established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy. |
| KYSE-180 | disease: carcinoma, squamous cell |
| KYSE-270 | disease: carcinoma, squamous cell |
| KYSE-30 | |
| KYSE-450 | disease: carcinoma, squamous cell |
| KYSE-510 | disease: carcinoma, squamous cell |
| KYSE-520 | disease: carcinoma, squamous cell |
| KYSE-70 | disease: carcinoma, squamous cell |
| L-363 | Multiple myeloma cell line expressing syndecan-1. |
| LCLC-103H | disease: carcinoma, large cell |
| LCLC-97TM1 | disease: carcinoma, large cell |
| LN-18 | Human brain, cerebrum; right temporal lobe, glioblastoma; glioma; grade IV cell line; established from a 65 years old white male. |
| LN-229 | Human brain, right frontal parieto-occipital cortex, glioblastoma cell line; established from a 60 years old white female. |
| LNCAP | Human prostate carcinoma, established from the left supraclavicular lymph node metastasis from a 50-year-old man with prostate carcinoma in 1977; cells were described to be androgen-sensitive. |
| LOU-NH91 | disease: carcinoma, squamous cell |
| LOVO | A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow. |
| LOX-IMVI | Human melanoma cell line. |
| LP-1 | |
| LS 174T | |
| LS 180 | Human, Caucasian, colon, adenocarcinoma, colorectal, cell line. Morphology: epithelial; Species: human, Caucasian female 58 year old; Tissue: colon; Tumor: adenocarcinoma, colorectal. |
| LS1034 | disease: colorectal carcinoma |
| LXF-289 | |
| LXFL529 | cell line derived from lung |
| M059J | disease: malignant glioblastoma; glioma |
| M059K | disease: malignant glioblastoma; glioma |
| MC116 | |
| MCAS | cell line derived from ovary |
| MCF 10A | |
| MCF-7 | A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.). |
| MCF10DCIS.COM | cell line derived from breast |
| MDA-MB-134-VI | disease: ductal carcinoma (mammary gland primary) |
| MDA-MB-157 | disease: carcinoma (mammary gland primary) |
| MDA-MB-175-VII | |
| MDA-MB-231 | |
| MDA-MB-330 | disease: carcinoma (mammary gland primary) |
| MDA-MB-361 | |
| MDA-MB-415 | disease: adenocarcinoma (mammary gland primary) |
| MDA-MB-435 | Was originally considered to be a breast cancer cell line but has since been identified as a melanoma cell line. |
| MDA-MB-436 | |
| MDA-MB-453 | |
| MDA-MB-468 | |
| MDST8 | cell line derived from large_intestine |
| ME-1 | disease: hybridoma |
| ME-180 | disease: epidermoid carcinoma (cervix primary) |
| MEL-HO | Human melanoma; established from the primary tumor of a woman with melanoma in 1976; cells express mRNA of the oncogene c-myc. |
| MEWO | Human skin malignant melanoma cell line. |
| MFM-223 | Human breast carcinoma; established from the pleural effusion of a post-menopausal breast cancer patient without any prior treatment (tumor: widespread ductal mammary carcinoma T4 N2 M1 with histological grade III); cells were described to express androgen, estrogen and progesterone receptors. |
| MG-63 | |
| MHH-ES-1 | |
| MHH-NB-11 | |
| MHH-PREB-1 | |
| MIA PACA-2 | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.) |
| MKN-1 | A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells. |
| MKN-45 | Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman. |
| MKN-7 | A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type. |
| MKN-74 | A immortal human stomach-derived cell line cell that has the characteristics: Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow. |
| ML-2 | |
| MM.1S | Human B lymphoblast multiple myeloma cell line. |
| MOLM-16 | Human acute myeloid leukemia cell line; established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (AML M0) after failed chemotherapy. |
| MOLP-2 | cell line derived from haematopoietic_and_lymphoid_tissue |
| MOLP-8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| MOR | |
| MS751 | disease: epidermoid carcinoma (cervix primary) |
| MT-3 | |
| MV-4-11 | Human acute myelocytic leukemia cell line. |
| MX-1 | Human breast carcinoma cell line; established in vitro from the primary infiltrating duct carcinoma of a 40 year-old caucasian female. |
| NALM-6 | |
| NAMALWA | |
| NCI-H1048 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H1092 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1155 | |
| NCI-H1299 | |
| NCI-H1355 | |
| NCI-H1373 | |
| NCI-H1395 | |
| NCI-H1435 | Non-small cell lung cancer cell line. |
| NCI-H1437 | |
| NCI-H146 | Small cell lung cancer cell line. |
| NCI-H1568 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1573 | disease: adenocarcinoma (lung primary) |
| NCI-H1581 | disease: large cell adenocarcinoma; non-small cell lung cancer |
| NCI-H1623 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1648 | disease: adenocarcinoma (lung primary) |
| NCI-H1650 | |
| NCI-H1651 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1666 | disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary) |
| NCI-H1693 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1703 | |
| NCI-H1734 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1770 | disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary) |
| NCI-H1781 | disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary) |
| NCI-H1792 | disease: adenocarcinoma (lung primary) |
| NCI-H1793 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1838 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1869 | disease: squamous cell carcinoma (lung primary) |
| NCI-H187 | |
| NCI-H1882 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H1915 | Human non-small cell lung cancer cell line. |
| NCI-H1930 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1944 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H196 | Small cell lung cancer cell line. |
| NCI-H1975 | |
| NCI-H2009 | |
| NCI-H2023 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2030 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2052 | disease: mesothelioma (pleura primary) |
| NCI-H2073 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H2081 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H209 | Small cell lung cancer cell line. |
| NCI-H2106 | disease: large cell neuro- endocrine carcinoma (lung primary) |
| NCI-H2110 | disease: non-small cell lung cancer (lung primary) |
| NCI-H2122 | |
| NCI-H2126 | |
| NCI-H2135 | disease: non-small cell lung cancer |
| NCI-H2170 | |
| NCI-H2171 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2172 | disease: non-small cell lung cancer |
| NCI-H2196 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2198 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2228 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H226 | |
| NCI-H23 | |
| NCI-H2347 | |
| NCI-H2369 | cell line derived from lung |
| NCI-H2373 | cell line derived from lung |
| NCI-H2452 | disease: mesothelioma |
| NCI-H2461 | cell line derived from lung |
| NCI-H2595 | cell line derived from lung |
| NCI-H2596 | cell line derived from lung |
| NCI-H2722 | cell line derived from lung |
| NCI-H2795 | cell line derived from lung |
| NCI-H28 | disease: mesothelioma (pleura primary) |
| NCI-H2803 | cell line derived from lung |
| NCI-H2804 | cell line derived from lung |
| NCI-H2810 | cell line derived from lung |
| NCI-H292 | Mucoepidermoid human lung carcinoma cell line; established from a black female 32 years old; Morphology: epithelial. |
| NCI-H322T | cell line derived from lung |
| NCI-H345 | Small cell lung cancer cell line. |
| NCI-H358 | |
| NCI-H441 | |
| NCI-H446 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H460 | |
| NCI-H510A | disease: carcinoma; small cell lung cancer (unknown primary) |
| NCI-H520 | |
| NCI-H522 | |
| NCI-H596 | Human lung adenosquamous carcinoma cell line; derived in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung. |
| NCI-H650 | disease: bronchioalveolar carci- noma; non-small cell lung cancer (lung primary) |
| NCI-H716 | |
| NCI-H727 | disease: carcinoid |
| NCI-H810 | disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer |
| NCI-H82 | |
| NCI-H820 | disease: papillary adenocarci- noma (lung primary) |
| NCI-H847 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H889 | Human small cell lung cancer cell line, established from a 69 years old caucasian female, derived from the lymph node, stage E carcinoma. |
| NCI-H920 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H929 | Human multiple myeloma cell line; established from the pleural effusion of a 62-year-old white woman with myeloma (IgAkappa) at relapse. |
| NCI-N417 | Small cell lung cancer cell line. |
| NCI-N87 | |
| NIH:OVCAR-3 | Human caucasian ovary adenocarcinoma cell line; established from a 60 years old caucasian female. |
| NTERA-2 | A human embryonal carcinoma (EC) stem cell line used as a model system for the study of neuronal differentiation |
| NU-DUL-1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| NUGC-2 | Human gastric adenocarcinoma cell line established from a 56-year-old female. |
| NUGC-3 | Human gastric adenocarcinoma cell line established from a 72-year-old male. |
| NUGC-4 | A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.). |
| OAW28 | |
| OAW42 | disease: cystoadenocarcinoma |
| OCI-AML2 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 65-year-old man with acute myeloid leukemia. |
| OCI-AML3 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 57-year-old man with acute myeloid leukemia. |
| OCI-AML5 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 77-year-old man with acute myeloid leukemia. |
| OCI-LY-10 | cell line derived from haematopoietic_and_lymphoid_tissue |
| OCI-LY-19 | cell line derived from haematopoietic_and_lymphoid_tissue |
| OCI-LY-3 | |
| OCI-LY-7 | |
| OCI-M1 | Human acute myeloid leukemia cell line; established from erythroleukemia blasts, AML M6, of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia. |
| OCI-M2 | Human acute myelocytic leukemia cell line; established in 1984 from the leukemic cells of a 56-year-old patient with erythroleukemia, AML-M6, representing the end stage of a previously identified myelodysplastic syndrome. |
| OCUM-1 | cell line derived from stomach |
| OKAJIMA | cell line derived from stomach |
| OPM-2 | |
| OUMS-23 | cell line derived from large_intestine |
| OV-90 | |
| OV56 | cell line derived from ovary |
| OV7 | cell line derived from ovary |
| OVCA 420 | Human epithelial ovarian cancer cell line. |
| OVCA 429 | Human epithelial ovarian cancer cell line. |
| OVCA 432 | Human epithelial ovarian cancer cell line. |
| OVCAR-4 | |
| OVCAR-5 | |
| OVCAR-8 | |
| OVCAR433 | Human epithelial ovarian cancer cell line. |
| OVISE | Human ovarian carcinoma cell line from clear cell adenocarcinoma. |
| OVKATE | Human ovarian carcinoma cell line from serous papillary adenocarcinoma. |
| OVMANA | Human ovarian carcinoma cell line from clear cell adenocarcinoma. |
| OVSAHO | Human ovarian carcinoma cell line from serous papillary adenocarcinoma. |
| OVTOKO | Human ovarian carcinoma cell line from clear cell adenocarcinoma. |
| PA-1 | Human ovary ascites teratocarcinoma cell line. The line was established from cells taken from ascitic fluid. |
| PA-TU-8902 | |
| PA-TU-8988S | |
| PA-TU-8988T | |
| PANC 02.03 | |
| PANC 03.27 | |
| PANC 04.03 | |
| PANC 05.04 | |
| PANC 08.13 | |
| PANC-1 | |
| PC-3 | |
| PE/CA-PJ15 | cell line derived from upper_aerodigestive_tract |
| PE01 | cell line derived from ovary |
| PFEIFFER | disease: diffuse large cell non-Hodgkins lymphoma (B lymphocyte primary) |
| PK-45H | A immortal human cell line cell that has the characteristics: Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491(Deposited from Tohoku Univ.). |
| PK-45P | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic carcinoma. RCB1973 is derived from the same patient. TKG0493(Deposited from Tohoku Univ.). |
| PK-59 | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.). |
| PK-8 | A immortal human cell line cell that has the characteristics: Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.). |
| PL-21 | cell line derived from haematopoietic_and_lymphoid_tissue |
| PL45 | disease: ductal adenocarcinoma; same patient as Panc 10.05 cells |
| PLC/PRF/5 | Human malignant liver hepatoma cell line; established from a 24-years-old human male. The line was originally contaminated with mycoplasma, and was cured by treatment with BM-cycline. The cells secrete HBsAg. |
| PSN1 | Human pancreatic adenocarcinoma cell line. |
| QGP-1 | Human pancreatic neuroendocrine tumor cell line. |
| RAJI | |
| RAMOS | Ramos cell line is an EBV-negative, HLA class 1 positive B-lymphoblastoid cell line derived from a Burkitt lymphoma |
| RC-K8 | cell line derived from blood |
| RCM-1 | |
| REC-1 | |
| RERF-GC-1B | cell line derived from stomach |
| RERF-LC-KJ | A immortal human cell line cell that has the characteristics: Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow. |
| RERF-LC-MS | |
| RERF-LC-OK | cell line derived from lung |
| RI-1 | |
| RKN | cell line derived from soft_tissue |
| RKO | |
| RKO-E6 | |
| RL | |
| RMG-I | Human tumor cell line from ovarian mesonephroid adenocarcinoma. |
| RMUG-S | cell line derived from ovary |
| RPMI 2650 | Human nasal septum squamous cell carinoma cell line; established from the pleural effusion of a 52-year-old man with anaplastic squamous cell carcinoma of the nasal septum in 1962. |
| RPMI 8226 | |
| RPMI-7951 | Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node. |
| RT-112 | Human urinary bladder transitional cell carcinoma established from the transitional cell carcinoma histological grade G2 excised from a female patient with untreated primary urinary bladder carcinoma in 1973. |
| RT4 | Human urinary bladder transitional cell carcinoma; established from a recurrent well-differentiated transitional papillary tumor of the urinary bladder (clinical stage T2, histological grade G1, treated with gold grains 2 years earlier and diathermy after recurrence 10 months later) of a 63-year-old man in 1968. |
| SC-1 | A immortal mouse embryo-derived cell line cell that has the characteristics: Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses. |
| SCC-15 | Human tongue squamous cell carcinoma cell line. |
| SCC-25 | Human squamous cell carcinoma cell line; established from the biopsy of a squamous cell carcinoma of the tongue of a 70-year-old man. |
| SCC-3 | |
| SCC-9 | disease: squamous cell carcinoma |
| SCLC-21H | disease: carcinoma, small cell |
| SCLC-22H | disease: carcinoma, small cell |
| SET-2 | Acute myeloid leukemia cell line. Human essential thrombocythemia cell line; established from the peripheral blood of a 71-year-old woman with essential thrombocythemia at megakaryoblastic leukemic transformation. |
| SF268 | |
| SF539 | |
| SIG-M5 | disease: leukemia, acute monocytic |
| SIHA | |
| SJCRH30 | The line was established from cells from the bone marrow of a child with rhabdomyosarcoma. Derived from a metastatic site of the bone marrow. The cells show ultrastructural elements of primitive skeletal muscle differentiation. |
| SK-BR-3 | Human breast adenocarcinoma cell line; established from a caucasian female 43 years old. Morphology: epithelial-like. |
| SK-CO-1 | disease: colorectal adenocarcinoma (colon primary) |
| SK-MEL-1 | |
| SK-MEL-2 | |
| SK-MEL-24 | disease: malignant melanoma |
| SK-MEL-28 | |
| SK-MEL-3 | |
| SK-MEL-30 | Human melanoma derived from tumor tissue (subcutis metastasis) of a 67-year-old Caucasian man with malignant melanoma in 1975. |
| SK-MEL-31 | disease: malignant melanoma |
| SK-MEL-5 | Human caucasian skin melanoma cell line; established from a 24 year old Caucasian female. Derived from: axillary node. |
| SK-MES-1 | |
| SK-MM-2 | |
| SK-N-AS | |
| SK-N-DZ | Neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a 2 years old caucasian female child with poorly differentiated embryonal neuroblastoma. |
| SK-N-FI | Neuroblastoma cell line; derived in 1979 from a bone marrow metastasis from a 11 year old Caucasian male with poorly differentiated embryonal neuroblastoma. |
| SK-N-SH | |
| SK-OV-3 | |
| SK23 | cell line derived from skin |
| SKM-1 | |
| SNU-1 | disease: gastric carcinoma |
| SNU-16 | |
| SNU-182 | |
| SNU-216 | Gastric cancer cell line. |
| SNU-387 | |
| SNU-398 | |
| SNU-423 | |
| SNU-449 | |
| SNU-475 | |
| SNU-484 | Human gastric cancer cell line. |
| SNU-5 | |
| SNU-601 | cell line derived from stomach |
| SNU-620 | Human gastric cancer cell line. |
| SNU-638 | Human gastric cancer cell line. |
| SNU-668 | cell line derived from stomach |
| SNU-719 | cell line derived from stomach |
| SNU-C1 | disease: adenocarcinoma colon primary) |
| SR | |
| SR-786 | |
| SU-DHL-1 | |
| SU-DHL-10 | |
| SU-DHL-16 | |
| SU-DHL-4 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SU-DHL-5 | |
| SU-DHL-6 | |
| SU-DHL-8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SU.86.86 | Homo sapiens (human) pancreatic adenocarcinoma cell line. The line was developed from a wedge biosy of a liver metastasis of a pancreatic ductal carcinoma. |
| SUIT-2 | Human pancreatic cancer cell line. |
| SUM 1315M02 | cell line derived from breast |
| SUM 149PT | |
| SUM 159PT | |
| SUM 229PE | Human breast cancer cell line from a primary tumor. |
| SUM 52PE | |
| SUP-B15 | disease: acute lymphoblastic leukemia |
| SW 1116 | |
| SW 1417 | |
| SW 1463 | |
| SW 1573 | |
| SW 1990 | |
| SW 403 | |
| SW 48 | |
| SW 480 | |
| SW 527 | disease: Pagets disease |
| SW 620 | |
| SW 780 | disease: transitional cell carcinoma |
| SW 837 | |
| SW 900 | |
| SW 948 | |
| SW 982 | disease: synovial sarcoma |
| T-47D | |
| T84 | |
| T98G | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.). |
| TC-71 | |
| TCC-PAN2 | cell line derived from pancreas |
| THP-1 | |
| TK | cell line derived from blood |
| TK-10 | TK-10 was derived from a specimen of primary RCC obtained following a left radical nephrectomy in a 43-year-old male on August 21, 1980. |
| TMD8 | |
| TOLEDO | disease: diffuse large cell lymphoma, non-Hodgkins |
| TOV-112D | TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer. |
| TYK-NU | |
| TYK-NU.CP-R | cell line derived from ovary |
| U-2 OS | |
| U-2932 | cell line derived from blood |
| U-698-M | disease: lymphoma, B cell |
| U-937 | |
| U266B1 | disease: plasmacytoma; myeloma |
| UACC-257 | |
| UACC-812 | disease: ductal carcinoma |
| UACC-893 | |
| UCSD-242L | cell line derived from skin |
| UKE-1 | Acute myeloid leukemia cell line. |
| UM-UC-1 | cell line derived from urinary_tract |
| UM-UC-3 | |
| UMC-11 | disease: carcinoid |
| VMRC-LCD | cell line derived from lung |
| WIDR | |
| WM-115 | |
| WM-266-4 | Homo sapiens (human) skin melanoma cell line. The WM-266-4 cell line was derived from a metastatic site of a malignant melanoma from a 58 year old female organism. |
| WSU-DLCL2 | cell line derived from haematopoietic_and_lymphoid_tissue |
| WSU-FSCCL | cell line derived from lymph node |
| WSU-NHL | |
| YAPC | |
| YMB-1 | Human breast cancer cell line; established from a 55 year-old human female. |
| YMB-1-E | Human breast cancer cell line; established from a 55 year-old female. |
| ZR-75-1 | |
| ZR-75-30 |
